Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H16FN3O2S |
Molecular Weight | 345.391 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CC=CN=C3
InChI
InChIKey=BFDBKMOZYNOTPK-UHFFFAOYSA-N
InChI=1S/C17H16FN3O2S/c1-19-10-13-9-17(15-6-2-3-7-16(15)18)21(12-13)24(22,23)14-5-4-8-20-11-14/h2-9,11-12,19H,10H2,1H3
Molecular Formula | C17H16FN3O2S |
Molecular Weight | 345.391 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:55:59 UTC 2023
by
admin
on
Sat Dec 16 01:55:59 UTC 2023
|
Record UNII |
1R5L3J156G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29701
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
||
|
NCI_THESAURUS |
C29723
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2604577
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
PRIMARY | |||
|
15981397
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
PRIMARY | |||
|
m11860
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
PRIMARY | |||
|
9535
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
PRIMARY | |||
|
4993
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
PRIMARY | |||
|
HI-57
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
PRIMARY | |||
|
1R5L3J156G
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
PRIMARY | |||
|
1R5L3J156G
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
PRIMARY | |||
|
Vonoprazan
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
PRIMARY | |||
|
100000181475
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
PRIMARY | |||
|
C152911
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
PRIMARY | |||
|
881681-00-1
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
PRIMARY | |||
|
DTXSID20236869
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
PRIMARY | |||
|
DB11739
Created by
admin on Sat Dec 16 01:55:59 UTC 2023 , Edited by admin on Sat Dec 16 01:55:59 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BINDER->LIGAND |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
CUMULATIVE EXCRETION |
URINE
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
EXCRETED UNCHANGED |
URINE
|
||
|
TARGET -> INHIBITOR |
reversible and potassium-competitive manner with a potency of inhibition approximately 350 times higher than the proton pump inhibitor, lansoprazole.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
||||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||